Publikationen, an denen er mitarbeitet Leocadio Rodríguez Mañas (24)

2024

  1. Association between endogenous plasma beta-hydroxy-beta-methylbutyrate levels and frailty in community-dwelling older people

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 15, Núm. 1, pp. 231-239

  2. Fat Mass Accounts for Insulin Resistance Impact on Functional Decline and Mortality in Nondiabetic Older Adults

    Journal of the American Medical Directors Association, Vol. 25, Núm. 3, pp. 448-453

  3. Frailty Influences the Relationship between the Soluble Receptor for Advanced Glycation-End Products and Mortality in Older Adults with Diabetes Mellitus

    Gerontology

  4. Relationship of endogenous plasma concentrations of β-hydroxy β-methyl butyrate (HMB) with frailty in community dwelling older adults with type-2 diabetes mellitus

    Journal of Nutrition, Health and Aging, Vol. 28, Núm. 6

2023

  1. Association Between Pulse Wave Velocity and Frailty, Disability, and Mortality in Community-Dwelling Older Adults

    JACC: Advances, Vol. 2, Núm. 5

  2. Differential utility of various frailty diagnostic tools in non-geriatric hospital departments of several countries: A longitudinal study

    European Journal of Clinical Investigation, Vol. 53, Núm. 7

  3. Risk of Frailty According to the Values of the Ankle-Brachial Index in the Toledo Study for Healthy Aging

    Journal of Frailty and Aging, Vol. 12, Núm. 1, pp. 24-29

2022

  1. Dual effects of insulin resistance on mortality and function in non-diabetic older adults: findings from the Toledo Study of Healthy Aging

    GeroScience, Vol. 44, Núm. 2, pp. 1095-1108

  2. The ability of eight frailty instruments to identify adverse outcomes across different settings: the FRAILTOOLS project

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 13, Núm. 3, pp. 1487-1501

2021

  1. A Comparison of Frailty Assessment Instruments in Different Clinical and Social Care Settings: The Frailtools Project

    Journal of the American Medical Directors Association, Vol. 22, Núm. 3, pp. 607.e7-607.e12

  2. Association between telomere length, frailty and death in older adults

    GeroScience, Vol. 43, Núm. 2, pp. 1015-1027

  3. Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women

    Nature Communications, Vol. 12, Núm. 1

  4. Higher sRAGE Levels Predict Mortality in Frail Older Adults with Cardiovascular Disease

    Gerontology, Vol. 67, Núm. 2, pp. 202-210

  5. Impact of nutritional status according to GLIM criteria on the risk of incident frailty and mortality in community-dwelling older adults

    Clinical Nutrition, Vol. 40, Núm. 3, pp. 1192-1198

  6. Relationship between self-reported visual impairment and worsening frailty transition states in older people: a longitudinal study

    Aging Clinical and Experimental Research, Vol. 33, Núm. 9, pp. 2491-2498

  7. Reply to the letter ‘Visual impairment and frailty in older people’

    Aging Clinical and Experimental Research

2020

  1. Monitoring and Intervention Technologies to Manage Diabetic Older Persons: The CAPACITY Case—A Pilot Study

    Frontiers in Endocrinology, Vol. 11

  2. Rapid Assessment at Hospital Admission of Mortality Risk From COVID-19: The Role of Functional Status

    Journal of the American Medical Directors Association, Vol. 21, Núm. 12, pp. 1798-1802.e2

2019

  1. FRAILTOOLS study protocol: A comprehensive validation of frailty assessment tools to screen and diagnose frailty in different clinical and social settings and to provide instruments for integrated care in older adults

    BMC Geriatrics, Vol. 19, Núm. 1

  2. Increased levels of soluble Receptor for Advanced Glycation End-products (RAGE) are associated with a higher risk of mortality in frail older adults

    Age and Ageing, Vol. 48, Núm. 5, pp. 691-697